Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a maintenance/version update to the page rather than changes to study information or functionality.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page footer’s software/site revision label was updated from v3.5.2 to v3.5.3, reflecting a minor platform maintenance change rather than any alteration to the study record content.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check64 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.3 was applied, replacing the previous v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded Revision: v3.4.2; removed the funding lapse notice and the previous Revision: v3.4.1. These changes pertain to site maintenance banners and do not affect study details.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.